4CPS-099 Clinically relevant drug–drug interaction events in patients with abiraterone, enzalutamide or apalutamide treatment

Autor:	J Bodega-Azuara, E Vicente-Escrig, T Cebolla-Beltrán, V Bosó-Ribelles, J Edo-Peñarrocha, M Fortanet-García, R Ferrando-Piqueres
Rok vydání:	2022
Zdroj:	Section 4: Clinical pharmacy services.
DOI:	10.1136/ejhpharm-2022-eahp.129
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0c25b9e069638a67a1d13c18c72b2da2 https://doi.org/10.1136/ejhpharm-2022-eahp.129 Zobrazit plný text záznamu